This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Abelzeta Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations by Wangqin Shu in Tumor-Infiltrating Lymphocyte Preparation
Introduction
Wangqin Shu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of cancer research, particularly in the preparation of tumor-infiltrating lymphocytes (TILs). His innovative methods have the potential to enhance cancer treatment by improving the availability of TILs for therapeutic use.
Latest Patents
Wangqin Shu holds 1 patent for his work titled "Methods for preparing tumor-infiltrating lymphocytes." This patent outlines methods for expanding TILs, which involve co-culturing an initial cell population containing TILs with first feeder cells to obtain a first expanded cell population. Subsequently, the first expanded cell population is co-cultured with second feeder cells to produce an expanded TIL population. These methods enable the rapid production of a large number of TILs from a small tumor sample, which is crucial for effective cancer therapies.
Career Highlights
Wangqin Shu is currently associated with Shanghai Abelzeta Ltd., where he continues to advance his research and innovations. His work is pivotal in the ongoing efforts to develop more effective cancer treatments through the utilization of TILs.
Collaborations
Wangqin Shu collaborates with talented individuals in his field, including Jia Li and Jiyan Hou. Their combined expertise contributes to the success of their research initiatives and the development of innovative solutions in cancer treatment.
Conclusion
Wangqin Shu's contributions to the field of cancer research through his innovative methods for preparing tumor-infiltrating lymphocytes are noteworthy. His work not only enhances the understanding of TILs but also paves the way for improved cancer therapies.